News About: Pharm. Industry
Kim named KPIC head
Kim Myung-sub, chairman of Guju Pharmaceutical Co. and third-term lawmaker, has been named the new president of the Korea Pharmaceutical Industry Cooperative (KPIC), replacing Park Jae-Don who ends his six-year term l...
Invida joins hands with Roche Korea
Invida Group Pte Ltd, the leading specialty biopharmaceutical company focusing on the commercialization of healthcare products throughout Asia Pacific, Tuesday announced that it has entered into an agreement with Roch...
Korea Eundan talks vitamin quality
Korea Eundan (KE) is emphasizing quality as the crucial point of differentiation between the vitamin C it produced and cheaper material from China.
Now it is leveraging that position with an ingredient brand that s...
Seniority-based culture losing momentum in pharmaceutical industry
The seniority-based culture has long have been a catalyst for the growth of pharmaceutical firms and at the same time as a headache.
Although having the oldest as a leader in a group embraces boosting effects and i...
Crystal Genomics not to acquire BexPharm Korea
Crystal Genomics and BexPharm Korea has recently agreed not to proceed any merger and acquisition (M&A) between both companies.
Crystal Genomics announced the M&A plan with BexPharm last May with a strong interest ...
Boryung Group to build 150 billion won plant
Boryung Pharmaceutical Group said Monday it will invest 150 billion won to build a complex plant producing drugs and other pharmaceutical products by 2014.
“To streamline the production of our healthcare products, ...
KPTA seeking to expand customer bases in US and China
The Korea Pharmaceutical Manufacturers Association (KPMA) has unveiled its plan to help Korean companies enlarge and diversify their customer bases in the United States and China.
In a meeting with representatives ...
Pharmaceutical companies eye non-pharmaceutical markets
Over-the-counter (OTC) drugs may emerge as the blue chips for domestic pharmaceutical companies as they are trying to find a breakthrough amid sagging momentum in the prescription market, which is forecast to become c...
Pharmaceutical companies fare well with generic drugs
Korea’s leading drugmakers saw their flagship generic products’ sales increasing due to robust demand last year, while the revenues in homegrown drugs were still discouraging.
According to Ubist market data, Hanmi ...
Multinational firms eyes local partnership
More and more foreign-invested firms are trying to seek strategic alliances with local firms for co-marketing of new drugs to effectively minimize outlays for sales and marketing.
Such alliance is widespread as ev...
